Global Felodipine Sustained-Release Tablet Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Felodipine Sustained-Release Tablet market size was valued at US$ million in 2023. With growing demand in downstream market, the Felodipine Sustained-Release Tablet is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Felodipine Sustained-Release Tablet market. Felodipine Sustained-Release Tablet are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Felodipine Sustained-Release Tablet. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Felodipine Sustained-Release Tablet market.
Felodipine sustained-release tablets are used to treat hypertension and stable angina pectoris.
Key Features:
The report on Felodipine Sustained-Release Tablet market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Felodipine Sustained-Release Tablet market. It may include historical data, market segmentation by Type (e.g., 2.5mg Per Tablet, 5mg Per Tablet), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Felodipine Sustained-Release Tablet market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Felodipine Sustained-Release Tablet market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Felodipine Sustained-Release Tablet industry. This include advancements in Felodipine Sustained-Release Tablet technology, Felodipine Sustained-Release Tablet new entrants, Felodipine Sustained-Release Tablet new investment, and other innovations that are shaping the future of Felodipine Sustained-Release Tablet.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Felodipine Sustained-Release Tablet market. It includes factors influencing customer ' purchasing decisions, preferences for Felodipine Sustained-Release Tablet product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Felodipine Sustained-Release Tablet market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Felodipine Sustained-Release Tablet market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Felodipine Sustained-Release Tablet market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Felodipine Sustained-Release Tablet industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Felodipine Sustained-Release Tablet market.
Market Segmentation:
Felodipine Sustained-Release Tablet market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Felodipine Sustained-Release Tablet market?
What factors are driving Felodipine Sustained-Release Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Felodipine Sustained-Release Tablet market opportunities vary by end market size?
How does Felodipine Sustained-Release Tablet break out type, application?
According to our LPI (LP Information) latest study, the global Felodipine Sustained-Release Tablet market size was valued at US$ million in 2023. With growing demand in downstream market, the Felodipine Sustained-Release Tablet is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Felodipine Sustained-Release Tablet market. Felodipine Sustained-Release Tablet are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Felodipine Sustained-Release Tablet. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Felodipine Sustained-Release Tablet market.
Felodipine sustained-release tablets are used to treat hypertension and stable angina pectoris.
Key Features:
The report on Felodipine Sustained-Release Tablet market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Felodipine Sustained-Release Tablet market. It may include historical data, market segmentation by Type (e.g., 2.5mg Per Tablet, 5mg Per Tablet), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Felodipine Sustained-Release Tablet market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Felodipine Sustained-Release Tablet market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Felodipine Sustained-Release Tablet industry. This include advancements in Felodipine Sustained-Release Tablet technology, Felodipine Sustained-Release Tablet new entrants, Felodipine Sustained-Release Tablet new investment, and other innovations that are shaping the future of Felodipine Sustained-Release Tablet.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Felodipine Sustained-Release Tablet market. It includes factors influencing customer ' purchasing decisions, preferences for Felodipine Sustained-Release Tablet product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Felodipine Sustained-Release Tablet market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Felodipine Sustained-Release Tablet market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Felodipine Sustained-Release Tablet market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Felodipine Sustained-Release Tablet industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Felodipine Sustained-Release Tablet market.
Market Segmentation:
Felodipine Sustained-Release Tablet market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 2.5mg Per Tablet
- 5mg Per Tablet
- Others
- Treat High Blood Pressure
- Relieve Angina
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astrazeneca
- NanJing Easeheal Phaemaecutical
- SHANXI KANGBO BIOLOGICAL PRODUCT
- Lifeon
- Changzhou Siyao Pharmaceutical
- Mylan
- Sandoz
What is the 10-year outlook for the global Felodipine Sustained-Release Tablet market?
What factors are driving Felodipine Sustained-Release Tablet market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Felodipine Sustained-Release Tablet market opportunities vary by end market size?
How does Felodipine Sustained-Release Tablet break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Felodipine Sustained-Release Tablet Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Country/Region, 2019, 2023 & 2030
2.2 Felodipine Sustained-Release Tablet Segment by Type
2.2.1 2.5mg Per Tablet
2.2.2 5mg Per Tablet
2.2.3 Others
2.3 Felodipine Sustained-Release Tablet Sales by Type
2.3.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
2.3.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Type (2019-2024)
2.3.3 Global Felodipine Sustained-Release Tablet Sale Price by Type (2019-2024)
2.4 Felodipine Sustained-Release Tablet Segment by Application
2.4.1 Treat High Blood Pressure
2.4.2 Relieve Angina
2.4.3 Others
2.5 Felodipine Sustained-Release Tablet Sales by Application
2.5.1 Global Felodipine Sustained-Release Tablet Sale Market Share by Application (2019-2024)
2.5.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Application (2019-2024)
2.5.3 Global Felodipine Sustained-Release Tablet Sale Price by Application (2019-2024)
3 GLOBAL FELODIPINE SUSTAINED-RELEASE TABLET BY COMPANY
3.1 Global Felodipine Sustained-Release Tablet Breakdown Data by Company
3.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Company (2019-2024)
3.1.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2019-2024)
3.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Company (2019-2024)
3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Company (2019-2024)
3.2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2019-2024)
3.3 Global Felodipine Sustained-Release Tablet Sale Price by Company
3.4 Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Felodipine Sustained-Release Tablet Product Location Distribution
3.4.2 Players Felodipine Sustained-Release Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FELODIPINE SUSTAINED-RELEASE TABLET BY GEOGRAPHIC REGION
4.1 World Historic Felodipine Sustained-Release Tablet Market Size by Geographic Region (2019-2024)
4.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Felodipine Sustained-Release Tablet Market Size by Country/Region (2019-2024)
4.2.1 Global Felodipine Sustained-Release Tablet Annual Sales by Country/Region (2019-2024)
4.2.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Country/Region (2019-2024)
4.3 Americas Felodipine Sustained-Release Tablet Sales Growth
4.4 APAC Felodipine Sustained-Release Tablet Sales Growth
4.5 Europe Felodipine Sustained-Release Tablet Sales Growth
4.6 Middle East & Africa Felodipine Sustained-Release Tablet Sales Growth
5 AMERICAS
5.1 Americas Felodipine Sustained-Release Tablet Sales by Country
5.1.1 Americas Felodipine Sustained-Release Tablet Sales by Country (2019-2024)
5.1.2 Americas Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)
5.2 Americas Felodipine Sustained-Release Tablet Sales by Type
5.3 Americas Felodipine Sustained-Release Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Felodipine Sustained-Release Tablet Sales by Region
6.1.1 APAC Felodipine Sustained-Release Tablet Sales by Region (2019-2024)
6.1.2 APAC Felodipine Sustained-Release Tablet Revenue by Region (2019-2024)
6.2 APAC Felodipine Sustained-Release Tablet Sales by Type
6.3 APAC Felodipine Sustained-Release Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Felodipine Sustained-Release Tablet by Country
7.1.1 Europe Felodipine Sustained-Release Tablet Sales by Country (2019-2024)
7.1.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)
7.2 Europe Felodipine Sustained-Release Tablet Sales by Type
7.3 Europe Felodipine Sustained-Release Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Felodipine Sustained-Release Tablet by Country
8.1.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2019-2024)
8.1.2 Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)
8.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type
8.3 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet
10.3 Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
10.4 Industry Chain Structure of Felodipine Sustained-Release Tablet
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Felodipine Sustained-Release Tablet Distributors
11.3 Felodipine Sustained-Release Tablet Customer
12 WORLD FORECAST REVIEW FOR FELODIPINE SUSTAINED-RELEASE TABLET BY GEOGRAPHIC REGION
12.1 Global Felodipine Sustained-Release Tablet Market Size Forecast by Region
12.1.1 Global Felodipine Sustained-Release Tablet Forecast by Region (2025-2030)
12.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Felodipine Sustained-Release Tablet Forecast by Type
12.7 Global Felodipine Sustained-Release Tablet Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Astrazeneca
13.1.1 Astrazeneca Company Information
13.1.2 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Astrazeneca Main Business Overview
13.1.5 Astrazeneca Latest Developments
13.2 NanJing Easeheal Phaemaecutical
13.2.1 NanJing Easeheal Phaemaecutical Company Information
13.2.2 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 NanJing Easeheal Phaemaecutical Main Business Overview
13.2.5 NanJing Easeheal Phaemaecutical Latest Developments
13.3 SHANXI KANGBO BIOLOGICAL PRODUCT
13.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
13.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Main Business Overview
13.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
13.4 Lifeon
13.4.1 Lifeon Company Information
13.4.2 Lifeon Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lifeon Main Business Overview
13.4.5 Lifeon Latest Developments
13.5 Changzhou Siyao Pharmaceutical
13.5.1 Changzhou Siyao Pharmaceutical Company Information
13.5.2 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Changzhou Siyao Pharmaceutical Main Business Overview
13.5.5 Changzhou Siyao Pharmaceutical Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Felodipine Sustained-Release Tablet Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Felodipine Sustained-Release Tablet by Country/Region, 2019, 2023 & 2030
2.2 Felodipine Sustained-Release Tablet Segment by Type
2.2.1 2.5mg Per Tablet
2.2.2 5mg Per Tablet
2.2.3 Others
2.3 Felodipine Sustained-Release Tablet Sales by Type
2.3.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
2.3.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Type (2019-2024)
2.3.3 Global Felodipine Sustained-Release Tablet Sale Price by Type (2019-2024)
2.4 Felodipine Sustained-Release Tablet Segment by Application
2.4.1 Treat High Blood Pressure
2.4.2 Relieve Angina
2.4.3 Others
2.5 Felodipine Sustained-Release Tablet Sales by Application
2.5.1 Global Felodipine Sustained-Release Tablet Sale Market Share by Application (2019-2024)
2.5.2 Global Felodipine Sustained-Release Tablet Revenue and Market Share by Application (2019-2024)
2.5.3 Global Felodipine Sustained-Release Tablet Sale Price by Application (2019-2024)
3 GLOBAL FELODIPINE SUSTAINED-RELEASE TABLET BY COMPANY
3.1 Global Felodipine Sustained-Release Tablet Breakdown Data by Company
3.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Company (2019-2024)
3.1.2 Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2019-2024)
3.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Company (2019-2024)
3.2.1 Global Felodipine Sustained-Release Tablet Revenue by Company (2019-2024)
3.2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2019-2024)
3.3 Global Felodipine Sustained-Release Tablet Sale Price by Company
3.4 Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Felodipine Sustained-Release Tablet Product Location Distribution
3.4.2 Players Felodipine Sustained-Release Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR FELODIPINE SUSTAINED-RELEASE TABLET BY GEOGRAPHIC REGION
4.1 World Historic Felodipine Sustained-Release Tablet Market Size by Geographic Region (2019-2024)
4.1.1 Global Felodipine Sustained-Release Tablet Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Felodipine Sustained-Release Tablet Market Size by Country/Region (2019-2024)
4.2.1 Global Felodipine Sustained-Release Tablet Annual Sales by Country/Region (2019-2024)
4.2.2 Global Felodipine Sustained-Release Tablet Annual Revenue by Country/Region (2019-2024)
4.3 Americas Felodipine Sustained-Release Tablet Sales Growth
4.4 APAC Felodipine Sustained-Release Tablet Sales Growth
4.5 Europe Felodipine Sustained-Release Tablet Sales Growth
4.6 Middle East & Africa Felodipine Sustained-Release Tablet Sales Growth
5 AMERICAS
5.1 Americas Felodipine Sustained-Release Tablet Sales by Country
5.1.1 Americas Felodipine Sustained-Release Tablet Sales by Country (2019-2024)
5.1.2 Americas Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)
5.2 Americas Felodipine Sustained-Release Tablet Sales by Type
5.3 Americas Felodipine Sustained-Release Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Felodipine Sustained-Release Tablet Sales by Region
6.1.1 APAC Felodipine Sustained-Release Tablet Sales by Region (2019-2024)
6.1.2 APAC Felodipine Sustained-Release Tablet Revenue by Region (2019-2024)
6.2 APAC Felodipine Sustained-Release Tablet Sales by Type
6.3 APAC Felodipine Sustained-Release Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Felodipine Sustained-Release Tablet by Country
7.1.1 Europe Felodipine Sustained-Release Tablet Sales by Country (2019-2024)
7.1.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)
7.2 Europe Felodipine Sustained-Release Tablet Sales by Type
7.3 Europe Felodipine Sustained-Release Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Felodipine Sustained-Release Tablet by Country
8.1.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2019-2024)
8.1.2 Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2019-2024)
8.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type
8.3 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet
10.3 Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
10.4 Industry Chain Structure of Felodipine Sustained-Release Tablet
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Felodipine Sustained-Release Tablet Distributors
11.3 Felodipine Sustained-Release Tablet Customer
12 WORLD FORECAST REVIEW FOR FELODIPINE SUSTAINED-RELEASE TABLET BY GEOGRAPHIC REGION
12.1 Global Felodipine Sustained-Release Tablet Market Size Forecast by Region
12.1.1 Global Felodipine Sustained-Release Tablet Forecast by Region (2025-2030)
12.1.2 Global Felodipine Sustained-Release Tablet Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Felodipine Sustained-Release Tablet Forecast by Type
12.7 Global Felodipine Sustained-Release Tablet Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Astrazeneca
13.1.1 Astrazeneca Company Information
13.1.2 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Astrazeneca Main Business Overview
13.1.5 Astrazeneca Latest Developments
13.2 NanJing Easeheal Phaemaecutical
13.2.1 NanJing Easeheal Phaemaecutical Company Information
13.2.2 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 NanJing Easeheal Phaemaecutical Main Business Overview
13.2.5 NanJing Easeheal Phaemaecutical Latest Developments
13.3 SHANXI KANGBO BIOLOGICAL PRODUCT
13.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
13.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Main Business Overview
13.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
13.4 Lifeon
13.4.1 Lifeon Company Information
13.4.2 Lifeon Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lifeon Main Business Overview
13.4.5 Lifeon Latest Developments
13.5 Changzhou Siyao Pharmaceutical
13.5.1 Changzhou Siyao Pharmaceutical Company Information
13.5.2 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Changzhou Siyao Pharmaceutical Main Business Overview
13.5.5 Changzhou Siyao Pharmaceutical Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Felodipine Sustained-Release Tablet Product Portfolios and Specifications
13.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Felodipine Sustained-Release Tablet Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Felodipine Sustained-Release Tablet Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 2.5mg Per Tablet
Table 4. Major Players of 5mg Per Tablet
Table 5. Major Players of Others
Table 6. Global Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 7. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Table 8. Global Felodipine Sustained-Release Tablet Revenue by Type (2019-2024) & ($ million)
Table 9. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2019-2024)
Table 10. Global Felodipine Sustained-Release Tablet Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Table 13. Global Felodipine Sustained-Release Tablet Revenue by Application (2019-2024)
Table 14. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2019-2024)
Table 15. Global Felodipine Sustained-Release Tablet Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Felodipine Sustained-Release Tablet Sales by Company (2019-2024) & (K Units)
Table 17. Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2019-2024)
Table 18. Global Felodipine Sustained-Release Tablet Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2019-2024)
Table 20. Global Felodipine Sustained-Release Tablet Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution and Sales Area
Table 22. Players Felodipine Sustained-Release Tablet Products Offered
Table 23. Felodipine Sustained-Release Tablet Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Felodipine Sustained-Release Tablet Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Felodipine Sustained-Release Tablet Sales Market Share Geographic Region (2019-2024)
Table 28. Global Felodipine Sustained-Release Tablet Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Felodipine Sustained-Release Tablet Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Felodipine Sustained-Release Tablet Sales Market Share by Country/Region (2019-2024)
Table 32. Global Felodipine Sustained-Release Tablet Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Felodipine Sustained-Release Tablet Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)
Table 35. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)
Table 36. Americas Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)
Table 38. Americas Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 39. Americas Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 40. APAC Felodipine Sustained-Release Tablet Sales by Region (2019-2024) & (K Units)
Table 41. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region (2019-2024)
Table 42. APAC Felodipine Sustained-Release Tablet Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Region (2019-2024)
Table 44. APAC Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 45. APAC Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 46. Europe Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)
Table 47. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)
Table 48. Europe Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)
Table 50. Europe Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 51. Europe Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Felodipine Sustained-Release Tablet
Table 59. Key Market Challenges & Risks of Felodipine Sustained-Release Tablet
Table 60. Key Industry Trends of Felodipine Sustained-Release Tablet
Table 61. Felodipine Sustained-Release Tablet Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Felodipine Sustained-Release Tablet Distributors List
Table 64. Felodipine Sustained-Release Tablet Customer List
Table 65. Global Felodipine Sustained-Release Tablet Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Felodipine Sustained-Release Tablet Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Felodipine Sustained-Release Tablet Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Felodipine Sustained-Release Tablet Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Felodipine Sustained-Release Tablet Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Felodipine Sustained-Release Tablet Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Felodipine Sustained-Release Tablet Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Astrazeneca Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 80. Astrazeneca Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 81. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Astrazeneca Main Business
Table 83. Astrazeneca Latest Developments
Table 84. NanJing Easeheal Phaemaecutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 85. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 86. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. NanJing Easeheal Phaemaecutical Main Business
Table 88. NanJing Easeheal Phaemaecutical Latest Developments
Table 89. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 90. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 91. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. SHANXI KANGBO BIOLOGICAL PRODUCT Main Business
Table 93. SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
Table 94. Lifeon Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 95. Lifeon Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 96. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Lifeon Main Business
Table 98. Lifeon Latest Developments
Table 99. Changzhou Siyao Pharmaceutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 100. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 101. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Changzhou Siyao Pharmaceutical Main Business
Table 103. Changzhou Siyao Pharmaceutical Latest Developments
Table 104. Mylan Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 105. Mylan Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 106. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Mylan Main Business
Table 108. Mylan Latest Developments
Table 109. Sandoz Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 110. Sandoz Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 111. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Sandoz Main Business
Table 113. Sandoz Latest Developments
Table 1. Felodipine Sustained-Release Tablet Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Felodipine Sustained-Release Tablet Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 2.5mg Per Tablet
Table 4. Major Players of 5mg Per Tablet
Table 5. Major Players of Others
Table 6. Global Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 7. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Table 8. Global Felodipine Sustained-Release Tablet Revenue by Type (2019-2024) & ($ million)
Table 9. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2019-2024)
Table 10. Global Felodipine Sustained-Release Tablet Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Table 13. Global Felodipine Sustained-Release Tablet Revenue by Application (2019-2024)
Table 14. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2019-2024)
Table 15. Global Felodipine Sustained-Release Tablet Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Felodipine Sustained-Release Tablet Sales by Company (2019-2024) & (K Units)
Table 17. Global Felodipine Sustained-Release Tablet Sales Market Share by Company (2019-2024)
Table 18. Global Felodipine Sustained-Release Tablet Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company (2019-2024)
Table 20. Global Felodipine Sustained-Release Tablet Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Felodipine Sustained-Release Tablet Producing Area Distribution and Sales Area
Table 22. Players Felodipine Sustained-Release Tablet Products Offered
Table 23. Felodipine Sustained-Release Tablet Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Felodipine Sustained-Release Tablet Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Felodipine Sustained-Release Tablet Sales Market Share Geographic Region (2019-2024)
Table 28. Global Felodipine Sustained-Release Tablet Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Felodipine Sustained-Release Tablet Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Felodipine Sustained-Release Tablet Sales Market Share by Country/Region (2019-2024)
Table 32. Global Felodipine Sustained-Release Tablet Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Felodipine Sustained-Release Tablet Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)
Table 35. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)
Table 36. Americas Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)
Table 38. Americas Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 39. Americas Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 40. APAC Felodipine Sustained-Release Tablet Sales by Region (2019-2024) & (K Units)
Table 41. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region (2019-2024)
Table 42. APAC Felodipine Sustained-Release Tablet Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Region (2019-2024)
Table 44. APAC Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 45. APAC Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 46. Europe Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)
Table 47. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)
Table 48. Europe Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)
Table 50. Europe Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 51. Europe Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Felodipine Sustained-Release Tablet
Table 59. Key Market Challenges & Risks of Felodipine Sustained-Release Tablet
Table 60. Key Industry Trends of Felodipine Sustained-Release Tablet
Table 61. Felodipine Sustained-Release Tablet Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Felodipine Sustained-Release Tablet Distributors List
Table 64. Felodipine Sustained-Release Tablet Customer List
Table 65. Global Felodipine Sustained-Release Tablet Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Felodipine Sustained-Release Tablet Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Felodipine Sustained-Release Tablet Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Felodipine Sustained-Release Tablet Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Felodipine Sustained-Release Tablet Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Felodipine Sustained-Release Tablet Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Felodipine Sustained-Release Tablet Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Felodipine Sustained-Release Tablet Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Astrazeneca Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 80. Astrazeneca Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 81. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. Astrazeneca Main Business
Table 83. Astrazeneca Latest Developments
Table 84. NanJing Easeheal Phaemaecutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 85. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 86. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. NanJing Easeheal Phaemaecutical Main Business
Table 88. NanJing Easeheal Phaemaecutical Latest Developments
Table 89. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 90. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 91. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. SHANXI KANGBO BIOLOGICAL PRODUCT Main Business
Table 93. SHANXI KANGBO BIOLOGICAL PRODUCT Latest Developments
Table 94. Lifeon Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 95. Lifeon Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 96. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Lifeon Main Business
Table 98. Lifeon Latest Developments
Table 99. Changzhou Siyao Pharmaceutical Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 100. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 101. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Changzhou Siyao Pharmaceutical Main Business
Table 103. Changzhou Siyao Pharmaceutical Latest Developments
Table 104. Mylan Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 105. Mylan Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 106. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Mylan Main Business
Table 108. Mylan Latest Developments
Table 109. Sandoz Basic Information, Felodipine Sustained-Release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 110. Sandoz Felodipine Sustained-Release Tablet Product Portfolios and Specifications
Table 111. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Sandoz Main Business
Table 113. Sandoz Latest Developments
LIST OF FIGURES
Figure 1. Picture of Felodipine Sustained-Release Tablet
Figure 2. Felodipine Sustained-Release Tablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Felodipine Sustained-Release Tablet Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Felodipine Sustained-Release Tablet Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Felodipine Sustained-Release Tablet Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 2.5mg Per Tablet
Figure 10. Product Picture of 5mg Per Tablet
Figure 11. Product Picture of Others
Figure 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Type in 2023
Figure 13. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2019-2024)
Figure 14. Felodipine Sustained-Release Tablet Consumed in Treat High Blood Pressure
Figure 15. Global Felodipine Sustained-Release Tablet Market: Treat High Blood Pressure (2019-2024) & (K Units)
Figure 16. Felodipine Sustained-Release Tablet Consumed in Relieve Angina
Figure 17. Global Felodipine Sustained-Release Tablet Market: Relieve Angina (2019-2024) & (K Units)
Figure 18. Felodipine Sustained-Release Tablet Consumed in Others
Figure 19. Global Felodipine Sustained-Release Tablet Market: Others (2019-2024) & (K Units)
Figure 20. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2023)
Figure 21. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application in 2023
Figure 22. Felodipine Sustained-Release Tablet Sales Market by Company in 2023 (K Units)
Figure 23. Global Felodipine Sustained-Release Tablet Sales Market Share by Company in 2023
Figure 24. Felodipine Sustained-Release Tablet Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company in 2023
Figure 26. Global Felodipine Sustained-Release Tablet Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)
Figure 29. Americas Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)
Figure 30. APAC Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)
Figure 31. APAC Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)
Figure 32. Europe Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)
Figure 33. Europe Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)
Figure 36. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023
Figure 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023
Figure 38. Americas Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Figure 39. Americas Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Figure 40. United States Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region in 2023
Figure 45. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Regions in 2023
Figure 46. APAC Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Figure 47. APAC Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Figure 48. China Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023
Figure 56. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023
Figure 57. Europe Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Figure 58. Europe Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Figure 59. Germany Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Figure 68. Egypt Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet in 2023
Figure 74. Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
Figure 75. Industry Chain Structure of Felodipine Sustained-Release Tablet
Figure 76. Channels of Distribution
Figure 77. Global Felodipine Sustained-Release Tablet Sales Market Forecast by Region (2025-2030)
Figure 78. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Felodipine Sustained-Release Tablet
Figure 2. Felodipine Sustained-Release Tablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Felodipine Sustained-Release Tablet Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Felodipine Sustained-Release Tablet Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Felodipine Sustained-Release Tablet Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 2.5mg Per Tablet
Figure 10. Product Picture of 5mg Per Tablet
Figure 11. Product Picture of Others
Figure 12. Global Felodipine Sustained-Release Tablet Sales Market Share by Type in 2023
Figure 13. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2019-2024)
Figure 14. Felodipine Sustained-Release Tablet Consumed in Treat High Blood Pressure
Figure 15. Global Felodipine Sustained-Release Tablet Market: Treat High Blood Pressure (2019-2024) & (K Units)
Figure 16. Felodipine Sustained-Release Tablet Consumed in Relieve Angina
Figure 17. Global Felodipine Sustained-Release Tablet Market: Relieve Angina (2019-2024) & (K Units)
Figure 18. Felodipine Sustained-Release Tablet Consumed in Others
Figure 19. Global Felodipine Sustained-Release Tablet Market: Others (2019-2024) & (K Units)
Figure 20. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2023)
Figure 21. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application in 2023
Figure 22. Felodipine Sustained-Release Tablet Sales Market by Company in 2023 (K Units)
Figure 23. Global Felodipine Sustained-Release Tablet Sales Market Share by Company in 2023
Figure 24. Felodipine Sustained-Release Tablet Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Felodipine Sustained-Release Tablet Revenue Market Share by Company in 2023
Figure 26. Global Felodipine Sustained-Release Tablet Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Felodipine Sustained-Release Tablet Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)
Figure 29. Americas Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)
Figure 30. APAC Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)
Figure 31. APAC Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)
Figure 32. Europe Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)
Figure 33. Europe Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Felodipine Sustained-Release Tablet Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Felodipine Sustained-Release Tablet Revenue 2019-2024 ($ Millions)
Figure 36. Americas Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023
Figure 37. Americas Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023
Figure 38. Americas Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Figure 39. Americas Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Figure 40. United States Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Felodipine Sustained-Release Tablet Sales Market Share by Region in 2023
Figure 45. APAC Felodipine Sustained-Release Tablet Revenue Market Share by Regions in 2023
Figure 46. APAC Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Figure 47. APAC Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Figure 48. China Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023
Figure 56. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023
Figure 57. Europe Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Figure 58. Europe Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Figure 59. Germany Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Felodipine Sustained-Release Tablet Sales Market Share by Application (2019-2024)
Figure 68. Egypt Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Felodipine Sustained-Release Tablet Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Felodipine Sustained-Release Tablet in 2023
Figure 74. Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
Figure 75. Industry Chain Structure of Felodipine Sustained-Release Tablet
Figure 76. Channels of Distribution
Figure 77. Global Felodipine Sustained-Release Tablet Sales Market Forecast by Region (2025-2030)
Figure 78. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Application (2025-2030)
